VeriMomHamilelikte peg-6 oleamine kullanmaktan kaçınmalı mıyım? | VeriMom
No EU Harmonised CLP (CLH) classification for reproductive toxicity (H360/H361 harmonised) was found on ECHA’s public registration/C&L listings; available ECHA REACH registration pages describe the substance but do not show a harmonised H360/H361 CLH entry. No SCCS or CIR safety assessment identifying reproductive hazard was found, and no peer‑reviewed animal or human reproductive/developmental toxicity studies specific to PEG‑6 oleamine were identified. Topical exposure from cosmetics is expected to give low but measurable systemic exposure for an ethoxylated surfactant, so adult exposure score =1. (Sources: ECHA registration page, PubChem/industry datasheets, CIR ingredient pages).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- peg-6 oleamine hamilelikte güvenli mi?
- No EU Harmonised CLP (CLH) classification for reproductive toxicity (H360/H361 harmonised) was found on ECHA’s public registration/C&L listings; available ECHA REACH registration pages describe the substance but do not show a harmonised H360/H361 CLH entry. No SCCS or CIR safety assessment identifying reproductive hazard was found, and no peer‑reviewed animal or human reproductive/developmental toxicity studies specific to PEG‑6 oleamine were identified. Topical exposure from cosmetics is expected to give low but measurable systemic exposure for an ethoxylated surfactant, so adult exposure score =1. (Sources: ECHA registration page, PubChem/industry datasheets, CIR ingredient pages).
- peg-6 oleamine emzirirken güvenli mi?
- Same rationale as pregnancy: no evidence of reproductive/developmental hazard or harmonised CLP. For breastfeeding, no data showing secretion in milk or neonatal toxicity were found; expected topical systemic exposure is low but measurable so exposure =1. No specific studies on milk transfer located.
- peg-6 oleamine bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental toxicity data were identified. Because infant skin (0–3 yr) has a less mature barrier and higher surface‑area‑to‑weight, exposure is increased by +1 relative to adults (adult e=1 → infant e=2). There is no evidence to upgrade hazard or mechanism for infants in the available literature and regulatory records.
- VeriMom peg-6 oleamine nasıl puanlıyor?
- VeriMom peg-6 oleamine'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 33/100 (yüksek risk) olarak puanlar.
- Hamilelikte peg-6 oleamine yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.